Chattanooga, Tenn. – June 19, 2013 – Hyundai Hope On Wheels® and Chattanooga-area Hyundai dealers awarded a $75,000 Hyundai Scholar Grant to the Center for Childhood Cancer and Blood Disorders at T.C. Thompson Children’s Hospital […]
Erlanger Health System is one of 6 hospitals in the United States participating in a clinical trial of a novel device called the Ischemic Stroke System (ISS) that may greatly increase the window of treatment for stroke victims. Current treatments allow for a maximum of 8–9 hours before irreversible tissue loss occurs. The ISS treatment would extend that window to 24 hours.